Magnetic Resonance or Computed Tomography and Bone Scan for Staging Metastatic Hormone–Sensitive Prostate Cancer
Whole-body magnetic resonance imaging appears to enhance staging accuracy and risk stratification in mHSPC, potentially influencing treatment decisions. While limited by retrospective design, these findings suggest that WB-MRI may optimise management in mHSPC, warranting further prospective validation.
Authors
- Daniel Wilby (ORCID: https://orcid.org/0009-0000-8807-0393)
- Shyamika Acharige
- Giuseppe Luigi Banna (ORCID: https://orcid.org/0000-0003-0764-3650)
- Maria Campione (ORCID: https://orcid.org/0009-0003-7899-4308)
- Mohd Ali Hassan (ORCID: https://orcid.org/0000-0001-9509-9266)
- Akash Maniam (ORCID: https://orcid.org/0000-0001-6189-0105)
- Tomasz P. Olejnik (ORCID: https://orcid.org/0000-0001-6941-4111)
- Maja Uherek
- Joanna Gale (ORCID: https://orcid.org/0000-0002-0285-5737)
- Utku Lokman (ORCID: https://orcid.org/0000-0003-0772-3319)
- Shobana Anpalakhan
- Hajra Iqbal
- Richard Robinson (ORCID: https://orcid.org/0000-0003-0104-6388)
- J.M. Buckley
- Naoko Atsumi (ORCID: https://orcid.org/0000-0001-6961-835X)
Institutions
- Università degli Studi di Enna Kore (IT)
- Southampton General Hospital (GB)
- University Hospital Southampton NHS Foundation Trust (GB)
- Portsmouth Hospitals NHS Trust (GB)
- University of Portsmouth (GB)
Publication Details
- Journal
- Clinical Medicine Insights Oncology
- Published
- 2025-05-06
- DOI
- https://doi.org/10.1177/11795549251335166
- Citations
- 1
- Primary Topic
- Prostate Cancer Treatment and Research
- Type
- article
- Field-Weighted Citation Impact
- 1.52